Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area

Article Abstract:

Most patients who develop severe acute respiratory syndrome (SARS) will survive unless they have diabetes or another chronic disease, according to a study of 144 patients in Toronto, Canada who developed SARS. Seventy-seven percent had been exposed to SARS in a hospital. Most had fever and a cough, and half had muscle pain and shortness of breath. Twenty percent were admitted to an intensive care unit and six percent died.

Canada, Mortality, Physiological aspects

---

Critically ill patients with severe acute respiratory syndrome

Article Abstract:

Severe acute respiratory syndrome (SARS) can cause critical illness in some people. Of 196 people in Toronto, Canada, who developed SARS, 38 became so sick they had to be admitted to an intensive care unit. Twenty-nine had to be put on a mechanical ventilator. One-third died and half of the patients on mechanical ventilation died. Some of the patients were healthcare workers who had contracted SARS from a patient.

Ontario, Toronto, Ontario

---

Is this patient dead, vegetative, or severely neurologically impaired?: assessing outcome for comatose survivors of cardiac arrest

Article Abstract:

An assessment of the accuracy and precision of the clinical examination in predicting poor outcome in post-cardiac arrest coma is presented. It is found that the chances of survival for patients in coma, who lacked pupillary and corneal reflexes for 24 hours, are very small.

Science & research, Care and treatment, Research, Cardiac arrest, Coma

Similar abstracts:

• Abstracts: Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Parathyroid hormone-related protein levels in maternal and cord blood
• Abstracts: The psychological needs of patients with chronic respiratory disease. An introduction to blood gas analysis
• Abstracts: Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
• Abstracts: The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intesinal ischemia-reperfusion

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.